Trials / Terminated
TerminatedNCT02240355
A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)
A Multicenter, Randomized, Double Blind, Placebo Controlled, Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO6885247 Following 12 Weeks of Treatment in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH).
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
This multicenter, randomized, double-blind, 12-week, placebo-controlled multiple dose study will investigate the safety and tolerability of RO6885247 in adult and pediatric patients with spinal muscular atrophy (SMA).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RO6885247 | oral solution |
| DRUG | placebo | oral solution |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2014-09-15
- Last updated
- 2016-12-22
Locations
26 sites across 9 countries: United States, Canada, France, Italy, Netherlands, Sweden, Switzerland, Turkey (Türkiye), United Kingdom
Source: ClinicalTrials.gov record NCT02240355. Inclusion in this directory is not an endorsement.